Matrix Metalloproteinase-Responsive Delivery of PEGylated Fibroblast Growth Factor 2Click to copy article linkArticle link copied!
- Marcus GutmannMarcus GutmannInstitute of Pharmacy and Food Chemistry, University of Würzburg, DE-97074 Würzburg, GermanyMore by Marcus Gutmann
- Debora ReinhardtDebora ReinhardtInstitute of Pharmacy and Food Chemistry, University of Würzburg, DE-97074 Würzburg, GermanyMore by Debora Reinhardt
- Christian SeidenstickerChristian SeidenstickerMedizinische Klinik und Poliklinik Für Innere Medizin II, Klinikum Rechts der Isar der TU München, Ismaninger Str. 22, 81675 Munich, GermanyMore by Christian Seidensticker
- Martina RaschigMartina RaschigInstitute of Pharmacy and Food Chemistry, University of Würzburg, DE-97074 Würzburg, GermanyMore by Martina Raschig
- Lukas HahnLukas HahnInstitute of Pharmacy and Food Chemistry, University of Würzburg, DE-97074 Würzburg, GermanyMore by Lukas Hahn
- Alessandra MoscaroliAlessandra MoscaroliCenter for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, CH-5232 Villigen PSI, SwitzerlandMore by Alessandra Moscaroli
- Martin BeheMartin BeheCenter for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, CH-5232 Villigen PSI, SwitzerlandMore by Martin Behe
- Lorenz MeinelLorenz MeinelInstitute of Pharmacy and Food Chemistry, University of Würzburg, DE-97074 Würzburg, GermanyHelmholtz Institute for RNA-Based Infection Research (HIRI), Helmholtz Center for Infection Research (HZI), DE-97080 Würzburg, GermanyMore by Lorenz Meinel
- Tessa Lühmann*Tessa Lühmann*Email: [email protected]. Tel.: +49 931 318 28 07. Fax: +49 931 318 46 08.Institute of Pharmacy and Food Chemistry, University of Würzburg, DE-97074 Würzburg, GermanyMore by Tessa Lühmann
Abstract
Attachment of polyethylene glycol (PEG) chains is a common, well-studied, and Food and Drug Administration-approved method to address the pharmacokinetic challenges of therapeutic proteins. Occasionally, PEGylation impairs the activity of pharmacodynamics (PD). To overcome this problem, disease-relevant cleavable linkers between the polymer and the therapeutic protein can unleash full PD by de-PEGylating the protein at its target site. In this study, we engineered a matrix metalloproteinase (MMP)-responsive fibroblast growth factor 2 (FGF-2) mutant that was site-specifically extended with a PEG polymer chain. Using bioinspired strategies, the bioconjugate was designed to release the native protein at the desired structure/environment with preservation of the proliferative capacity in vitro on NIH3T3 cells. In vivo, hepatic exposure was diminished but not its renal distribution over time compared to unconjugated FGF-2. By releasing the growth factor from the PEG polymer in response to MMP cleavage, restored FGF-2 may enter hard-to-reach tissues and activate cell surface receptors or nuclear targets.
Cited By
This article has not yet been cited by other publications.
Article Views
Altmetric
Citations
Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.
Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.
The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated.